The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.
Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies
Open accessAbstract
Hepatocellular carcinoma (HCC) is a significant cause of cancer-related mortality owing to resistance to traditional treatments and tumor recurrence after therapy, which leads to poor therapeutic outcomes. Cancer stem cells (CSC) are a small subset of tumor cells with the capability to influence self-renewal, differentiation, and tumorigenesis. A number of surface markers for liver cancer stem cell (LCSC) subpopulations (EpCAM, CD133, CD44, CD13, CD90, OV-6, CD47, and side populations) in HCC have been identified. LCSCs play critical roles in regulating HCC stemness, self-renewal, tumorigenicity, metastasis, recurrence, and therapeutic resistance via genetic mutations, epigenetic disruption, signaling pathway dysregulation, or alterations microenvironment. Accumulating studies have shown that biomarkers for LCSCs contribute to diagnosis and prognosis prediction of HCC, supporting their utility in clinical management and development of therapeutic strategies. Preclinical and clinical analyses of therapeutic approaches for HCC using small molecule inhibitors, oncolytic measles viruses, and anti-surface marker antibodies have demonstrated selective, efficient, and safe targeting of LCSC populations. The current review focuses on recent reports on the influence of LCSCs on HCC stemness, tumorigenesis, and multiple drug resistance (MDR), along with LCSC-targeted therapeutic strategies for HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
Notch Signaling: Cell Fate Control and Signal Integration in Development
Artavanis-Tsakonas, S., Rand, M. D., & Lake, R. J. (1999) · Science · doi:10.1126/science.284.5415.770 · Cited by 5,909
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
O’Brien, C. A., Pollett, A., Gallinger, S., & Dick, J. E. (2007) · Nature · doi:10.1038/nature05372 · Cited by 4,087
Identification of Pancreatic Cancer Stem Cells
Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., Wicha, M., Clarke, M. F., & Simeone, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2030 · Cited by 3,339
Cancer epigenetics: from mechanism to therapy
Dawson, M. A., & Kouzarides, T. (2012) · Cell · doi:10.1016/j.cell.2012.06.013 · Cited by 3,203
Functional interaction of β-catenin with the transcription factor LEF-1
Behrens, J., von Kries, J. P., Kühl, M., Bruhn, L., Wedlich, D., Grosschedl, R., & Birchmeier, W. (1996) · Nature · doi:10.1038/382638a0 · Cited by 2,912
Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.
Goodell, M. A., Brose, K., Paradis, G., Conner, A. S., & Mulligan, R. C. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1797 · Cited by 2,903
Hermann, P. C., Huber, S. L., Herrler, T., Aicher, A., Ellwart, J. W., Guba, M., Bruns, C. J., & Heeschen, C. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.06.002 · Cited by 2,897
A decade of exploring the cancer epigenome—biological and translational implications
Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871
Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer
Kim, C. F. B., Jackson, E. L., Woolfenden, A. E., Lawrence, S., Babar, I., Vogel, S., Crowley, D., Bronson, R. T., & Jacks, T. (2005) · Cell · doi:10.1016/j.cell.2005.03.032 · Cited by 2,195
Willingham, S. B., Volkmer, J.-P., Gentles, A. J., Sahoo, D., Dalerba, P., Mitra, S. S., Wang, J., Contreras-Trujillo, H., Martin, R., Cohen, J. D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121623109 · Cited by 1,666
Molecular pathogenesis of human hepatocellular carcinoma
Thorgeirsson, S. S., & Grisham, J. W. (2002) · Nature Genetics · doi:10.1038/ng0802-339 · Cited by 1,439
Identification and Characterization of Tumorigenic Liver Cancer Stem/Progenitor Cells
Ma, S., Chan, K., Hu, L., Lee, T. K., Wo, J. Y., Ng, I. O., Zheng, B., & Guan, X. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.025 · Cited by 1,192
Significance of CD90+ Cancer Stem Cells in Human Liver Cancer
Yang, Z. F., Ho, D. W., Ng, M. N., Lau, C. K., Yu, W. C., Ngai, P., Chu, P. W. K., Lam, C. T., Poon, R. T. P., & Fan, S. T. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.013 · Cited by 1,188
Yamashita, T., Ji, J., Budhu, A., Forgues, M., Yang, W., Wang, H., Jia, H., Ye, Q., Qin, L., Wauthier, E., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.004 · Cited by 1,149
The role of signaling pathways in the development and treatment of hepatocellular carcinoma
Whittaker, S., Marais, R., & Zhu, A. X. (2010) · Oncogene · doi:10.1038/onc.2010.236 · Cited by 825
Ma, S., Lee, T. K., Zheng, B.-J., Chan, K. W., & Guan, X.-Y. (2008) · Oncogene · doi:10.1038/sj.onc.1210811 · Cited by 775
Nuclear signalling by tumour-associated antigen EpCAM
Maetzel, D., Denzel, S., Mack, B., Canis, M., Went, P., Benk, M., Kieu, C., Papior, P., Baeuerle, P. A., Munz, M., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1824 · Cited by 719
Wan, S., Zhao, E., Kryczek, I., Vatan, L., Sadovskaya, A., Ludema, G., Simeone, D. M., Zou, W., & Welling, T. H. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.039 · Cited by 675
Chiba, T., Kita, K., Zheng, Y.-W., Yokosuka, O., Saisho, H., Iwama, A., Nakauchi, H., & Taniguchi, H. (2006) · Hepatology · doi:10.1002/hep.21227 · Cited by 664
The teratogenic Veratrum alkaloid cyclopamine inhibits Sonic hedgehog signal transduction
Incardona, J. P., Gaffield, W., Kapur, R. P., & Roelink, H. (1998) · Development · doi:10.1242/dev.125.18.3553 · Cited by 656
A repeating amino acid motif shared by proteins with diverse cellular roles
Peifer, M., Berg, S., & Reynolds, A. B. (1994) · Cell · doi:10.1016/0092-8674(94)90353-0 · Cited by 648
Wang, Y., He, L., Du, Y., Zhu, P., Huang, G., Luo, J., Yan, X., Ye, B., Li, C., Xia, P., et al. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.03.003 · Cited by 634
Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells
Suetsugu, A., Nagaki, M., Aoki, H., Motohashi, T., Kunisada, T., & Moriwaki, H. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.128 · Cited by 609
Underhill, C. (1992) · Journal of Cell Science · doi:10.1242/jcs.103.2.293 · Cited by 609
CD13 is a therapeutic target in human liver cancer stem cells
Haraguchi, N., Ishii, H., Mimori, K., Tanaka, F., Ohkuma, M., Kim, H. M., Akita, H., Takiuchi, D., Hatano, H., Nagano, H., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42550 · Cited by 605
Lee, T. K. W., Castilho, A., Cheung, V. C. H., Tang, K. H., Ma, S., & Ng, I. O. L. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.06.005 · Cited by 586
Targeting the Sonic Hedgehog Signaling Pathway: Review of Smoothened and GLI Inhibitors
Rimkus, T., Carpenter, R., Qasem, S., Chan, M., & Lo, H.-W. (2016) · Cancers · doi:10.3390/cancers8020022 · Cited by 581
Epithelial Cell Adhesion Molecule
Trzpis, M., McLaughlin, P. M. J., de Leij, L. M. F. H., & Harmsen, M. C. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070152 · Cited by 578
Characterization of a Side Population of Cancer Cells from Human Gastrointestinal System
Haraguchi, N., Utsunomiya, T., Inoue, H., Tanaka, F., Mimori, K., Barnard, G. F., & Mori, M. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0282 · Cited by 569
Genomics and Signaling Pathways in Hepatocellular Carcinoma
Villanueva, A., Newell, P., Chiang, D., Friedman, S., & Llovet, J. (2007) · Seminars in Liver Disease · doi:10.1055/s-2006-960171 · Cited by 556
CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity
Yin, S., Li, J., Hu, C., Chen, X., Yao, M., Yan, M., Jiang, G., Ge, C., Xie, H., Wan, D., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22476 · Cited by 555
EpCAM (CD326) finding its role in cancer
Baeuerle, P. A., & Gires, O. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603494 · Cited by 527
Cancer stem cells in the development of liver cancer
Yamashita, T., & Wang, X. W. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66024 · Cited by 525
The Emerging Role of EpCAM in Cancer and Stem Cell Signaling
Munz, M., Baeuerle, P. A., & Gires, O. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0654 · Cited by 515
Aldehyde Dehydrogenase Discriminates the CD133 Liver Cancer Stem Cell Populations
Ma, S., Chan, K. W., Lee, T. K.-W., Tang, K. H., Wo, J. Y.-H., Zheng, B.-J., & Guan, X.-Y. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0035 · Cited by 459
Fan, Q.-M., Jing, Y.-Y., Yu, G.-F., Kou, X.-R., Ye, F., Gao, L., Li, R., Zhao, Q.-D., Yang, Y., Lu, Z.-H., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.05.008 · Cited by 458
Activation of Hepatic Stem Cell Marker EpCAM by Wnt–β-Catenin Signaling in Hepatocellular Carcinoma
Yamashita, T., Budhu, A., Forgues, M., & Wang, X. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0908 · Cited by 446
Zhu, Z., Hao, X., Yan, M., Yao, M., Ge, C., Gu, J., & Li, J. (2010) · International Journal of Cancer · doi:10.1002/ijc.24868 · Cited by 434
Roles for Hedgehog signaling in adult organ homeostasis and repair
Petrova, R., & Joyner, A. L. (2014) · Development · doi:10.1242/dev.083691 · Cited by 415
Yuan, S., Wang, J., Yang, F., Tao, Q., Zhang, J., Wang, L., Yang, Y., Liu, H., Wang, Z., Xu, Q., et al. (2016) · Hepatology · doi:10.1002/hep.27893 · Cited by 404
Sun, Y.-F., Xu, Y., Yang, X.-R., Guo, W., Zhang, X., Qiu, S.-J., Shi, R.-Y., Hu, B., Zhou, J., & Fan, J. (2013) · Hepatology · doi:10.1002/hep.26151 · Cited by 404
The role of CD133 in cancer: a concise review
Glumac, P. M., & LeBeau, A. M. (2018) · Clinical and Translational Medicine · doi:10.1186/s40169-018-0198-1 · Cited by 400
GDC-0449—A potent inhibitor of the hedgehog pathway
Robarge, K. D., Brunton, S. A., Castanedo, G. M., Cui, Y., Dina, M. S., Goldsmith, R., Gould, S. E., Guichert, O., Gunzner, J. L., Halladay, J., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.08.049 · Cited by 386
Hematopoietic differentiation antigens that are membrane-associated enzymes: cutting is the key!
Shipp, M., & Look, A. (1993) · Blood · doi:10.1182/blood.v82.4.1052.1052 · Cited by 384
Ma, S., Tang, K. H., Chan, Y. P., Lee, T. K., Kwan, P. S., Castilho, A., Ng, I., Man, K., Wong, N., To, K.-F., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.11.010 · Cited by 383
Xia, H., Ooi, L. L. P. J., & Hui, K. M. (2013) · Hepatology · doi:10.1002/hep.26369 · Cited by 378
Wnt/β-Catenin Signaling Contributes to Activation of Normal and Tumorigenic Liver Progenitor Cells
Yang, W., Yan, H.-X., Chen, L., Liu, Q., He, Y.-Q., Yu, L.-X., Zhang, S.-H., Huang, D.-D., Tang, L., Kong, X.-N., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6691 · Cited by 378
dishevelled and armadillo act in the Wingless signalling pathway in Drosophila
Noordermeer, J., Klingensmith, J., Perrimon, N., & Nusse, R. (1994) · Nature · doi:10.1038/367080a0 · Cited by 377
Long noncoding RNA: an emerging paradigm of cancer research
Qiu, M.-T., Hu, J.-W., Yin, R., & Xu, L. (2013) · Tumor Biology · doi:10.1007/s13277-013-0658-6 · Cited by 375
Identification of local and circulating cancer stem cells in human liver cancer
Yang, Z. F., Ngai, P., Ho, D. W., Yu, W. C., Ng, M. N. P., Lau, C. K., Li, M. L. Y., Tam, K. H., Lam, C. T., Poon, R. T. P., et al. (2008) · Hepatology · doi:10.1002/hep.22082 · Cited by 349
Lau, E. Y. T., Lo, J., Cheng, B. Y. L., Ma, M. K. F., Lee, J. M. F., Ng, J. K. Y., Chai, S., Lin, C. H., Tsang, S. Y., Ma, S., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.019 · Cited by 334
Bourguignon, L. Y. W. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.007 · Cited by 305
Kopan, R. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a011213 · Cited by 294
Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis
Wang, X., Sun, W., Shen, W., Xia, M., Chen, C., Xiang, D., Ning, B., Cui, X., Li, H., Li, X., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.019 · Cited by 290
Postovit, L.-M., Margaryan, N. V., Seftor, E. A., Kirschmann, D. A., Lipavsky, A., Wheaton, W. W., Abbott, D. E., Seftor, R. E. B., & Hendrix, M. J. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800467105 · Cited by 286
Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma
Yamashita, T., Honda, M., Nakamoto, Y., Baba, M., Nio, K., Hara, Y., Zeng, S. S., Hayashi, T., Kondo, M., Takatori, H., et al. (2013) · Hepatology · doi:10.1002/hep.26168 · Cited by 281
Prolonged Drug Selection of Breast Cancer Cells and Enrichment of Cancer Stem Cell Characteristics
Calcagno, A. M., Salcido, C. D., Gillet, J.-P., Wu, C.-P., Fostel, J. M., Mumau, M. D., Gottesman, M. M., Varticovski, L., & Ambudkar, S. V. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq361 · Cited by 279
Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis
Sicklick, J. K., Li, Y.-X., Jayaraman, A., Kannangai, R., Qi, Y., Vivekanandan, P., Ludlow, J. W., Owzar, K., Chen, W., Torbenson, M. S., et al. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi292 · Cited by 270
Mohammed, M. K., Shao, C., Wang, J., Wei, Q., Wang, X., Collier, Z., Tang, S., Liu, H., Zhang, F., Huang, J., et al. (2016) · Genes & Diseases · doi:10.1016/j.gendis.2015.12.004 · Cited by 259
Persistent Sonic Hedgehog Signaling in Adult Brain Determines Neural Stem Cell Positional Identity
Ihrie, R. A., Shah, J. K., Harwell, C. C., Levine, J. H., Guinto, C. D., Lezameta, M., Kriegstein, A. R., & Alvarez-Buylla, A. (2011) · Neuron · doi:10.1016/j.neuron.2011.05.018 · Cited by 255
Targeting the Wnt pathway in human cancers: Therapeutic targeting with a focus on OMP-54F28
Le, P. N., McDermott, J. D., & Jimeno, A. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.08.005 · Cited by 253
Molecular pathogenesis of human hepatocellular carcinoma
Wang, X. W., Hussain, S. P., Huo, T.-I., Wu, C.-G., Forgues, M., Hofseth, L. J., Brechot, C., & Harris, C. C. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00253-6 · Cited by 246
Philip, P. A., Mooney, M., Jaffe, D., Eckhardt, G., Moore, M., Meropol, N., Emens, L., O'Reilly, E., Korc, M., Ellis, L., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.9022 · Cited by 240
lnc-β-Catm elicits EZH2-dependent β-catenin stabilization and sustains liver CSC self-renewal
Zhu, P., Wang, Y., Huang, G., Ye, B., Liu, B., Wu, J., Du, Y., He, L., & Fan, Z. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3235 · Cited by 231
Song, W., Li, H., Tao, K., Li, R., Song, Z., Zhao, Q., Zhang, F., & Dou, K. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01777.x · Cited by 226
Epigenetic Regulation of Cancer Stem Cell Marker Cd133 by Transforming Growth Factor-β
You, H., Ding, W., & Rountree, B. C. (2010) · Hepatology · doi:10.1002/hep.23544 · Cited by 221
Mima, K., Okabe, H., Ishimoto, T., Hayashi, H., Nakagawa, S., Kuroki, H., Watanabe, M., Beppu, T., Tamada, M., Nagano, O., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0299 · Cited by 215
Clinical Implications of Cancer Stem Cell Biology in Hepatocellular Carcinoma
Ji, J., & Wang, X. W. (2012) · Seminars in Oncology · doi:10.1053/j.seminoncol.2012.05.011 · Cited by 210
Hedgehog signaling: modulation of cancer properies and tumor mircroenvironment
Hanna, A., & Shevde, L. A. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0509-3 · Cited by 205
Cancer Stem Cells and Chemosensitivity
Maugeri-Saccà, M., Vigneri, P., & De Maria, R. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2538 · Cited by 201
Liver Cancer Initiation Requires p53 Inhibition by CD44-Enhanced Growth Factor Signaling
Dhar, D., Antonucci, L., Nakagawa, H., Kim, J. Y., Glitzner, E., Caruso, S., Shalapour, S., Yang, L., Valasek, M. A., Lee, S., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.05.003 · Cited by 200
Lo, J., Lau, E. Y. T., Ching, R. H. H., Cheng, B. Y. L., Ma, M. K. F., Ng, I. O. L., & Lee, T. K. W. (2015) · Hepatology · doi:10.1002/hep.27859 · Cited by 199
Post‐translational regulation of TGF‐β receptor and Smad signaling
Xu, P., Liu, J., & Derynck, R. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.05.010 · Cited by 198
CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma
Piao, L. S., Hur, W., Kim, T.-K., Hong, S. W., Kim, S. W., Choi, J. E., Sung, P. S., Song, M. J., Lee, B.-C., Hwang, D., et al. (2012) · Cancer Letters · doi:10.1016/j.canlet.2011.10.012 · Cited by 197
Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers
Oikawa, T., Kamiya, A., Zeniya, M., Chikada, H., Hyuck, A. D., Yamazaki, Y., Wauthier, E., Tajiri, H., Miller, L. D., Wang, X. W., et al. (2013) · Hepatology · doi:10.1002/hep.26159 · Cited by 195
Wang, L., Su, W., Liu, Z., Zhou, M., Chen, S., Chen, Y., Lu, D., Liu, Y., Fan, Y., Zheng, Y., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.067 · Cited by 193
Self-citationChen, Z.-Z., Huang, L., Wu, Y.-H., Zhai, W.-J., Zhu, P.-P., & Gao, Y.-F. (2016) · Nature Communications · doi:10.1038/ncomms12598 · Cited by 193
Octamer 4/microRNA‐1246 signaling axis drives Wnt/β‐catenin activation in liver cancer stem cells
Chai, S., Ng, K., Tong, M., Lau, E. Y., Lee, T. K., Chan, K. W., Yuan, Y., Cheung, T., Cheung, S., Wang, X., et al. (2016) · Hepatology · doi:10.1002/hep.28821 · Cited by 188
A small-molecule inhibitor of Tcf/β-catenin signaling down-regulates PPARγ and PPARδ activities
Handeli, S., & Simon, J. A. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2063 · Cited by 183
Kim, H. M., Haraguchi, N., Ishii, H., Ohkuma, M., Okano, M., Mimori, K., Eguchi, H., Yamamoto, H., Nagano, H., Sekimoto, M., et al. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-011-2040-5 · Cited by 165
Philips, G. M., Chan, I. S., Swiderska, M., Schroder, V. T., Guy, C., Karaca, G. F., Moylan, C., Venkatraman, T., Feuerlein, S., Syn, W.-K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023943 · Cited by 165
Regenerating the skin: a task for the heterogeneous stem cell pool and surrounding niche
Solanas, G., & Benitah, S. A. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3675 · Cited by 165
Wang, R., Li, Y., Tsung, A., Huang, H., Du, Q., Yang, M., Deng, M., Xiong, S., Wang, X., Zhang, L., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722100115 · Cited by 165
TGF-β family signaling in stem cells
Sakaki‐Yumoto, M., Katsuno, Y., & Derynck, R. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.08.008 · Cited by 163
Takigawa, Y., & Brown, A. (2008) · Current Drug Targets · doi:10.2174/138945008786786127 · Cited by 160
Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells
Wang, R., Sun, Q., Wang, P., Liu, M., Xiong, S., Luo, J., Huang, H., Du, Q., Geller, D. A., & Cheng, B. (2016) · Oncotarget · doi:10.18632/oncotarget.6805 · Cited by 159
Shi, G., Xu, Y., Fan, J., Zhou, J., Yang, X., Qiu, S., Liao, Y., Wu, W., Ji, Y., Ke, A., et al. (2008) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-008-0407-1 · Cited by 156
Zhou, J., Zeng, Q., Wang, H., Zhang, B., Li, S., Nan, X., Cao, N., Fu, C., Yan, X., Jia, Y., et al. (2015) · Hepatology · doi:10.1002/hep.27887 · Cited by 155
Fan, S. T., Yang, Z. F., Ho, D. W., Ng, M. N. P., Yu, W. C., & Wong, J. (2011) · Annals of Surgery · doi:10.1097/sla.0b013e3182300a1d · Cited by 155
Hedgehog Signaling Pathway Regulates Autophagy in Human Hepatocellular Carcinoma Cells
Wang, Y., Han, C. L., Lu, L., Magliato, S. A., & Wu, T. (2013) · Hepatology · doi:10.1002/hep.26394 · Cited by 155
CD44-Mediated Oncogenic Signaling and Cytoskeleton Activation During Mammary Tumor Progression
Bourguignon, L. (2001) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1011371523994 · Cited by 152
Targeting histone modifications — epigenetics in cancer
Waldmann, T., & Schneider, R. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.01.001 · Cited by 151
Fu, J., Rodova, M., Roy, S. K., Sharma, J. P., Singh, K. P., Srivastava, R. K., & Shankar, S. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.11.018 · Cited by 148
Chen, H., Li, H., Li, J., Zhu, Z. G., Yin, S., Hao, X., Yao, M., Zheng, S.-S., & Gu, J. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn223 · Cited by 146
Thy-1 binds to integrin β3 on astrocytes and triggers formation of focal contact sites
Leyton, L., Schneider, P., Labra, C. V., Rüegg, C., Hetz, C. A., Quest, A. F. G., & Bron, C. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00262-7 · Cited by 146
Zhu, P., Wang, Y., Du, Y., He, L., Huang, G., Zhang, G., Yan, X., & Fan, Z. (2015) · Nature Communications · doi:10.1038/ncomms8122 · Cited by 143
CD24 Is a Novel Predictor for Poor Prognosis of Hepatocellular Carcinoma after Surgery
Yang, X., Xu, Y., Yu, B., Zhou, J., Li, J., Qiu, S., Shi, Y., Wang, X., Dai, Z., Shi, G., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0151 · Cited by 142
The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma
Zeng, S. S., Yamashita, T., Kondo, M., Nio, K., Hayashi, T., Hara, Y., Nomura, Y., Yoshida, M., Hayashi, T., Oishi, N., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.08.024 · Cited by 140
Bourguignon, L., Shiina, M., & Li, J. J. (2014) · Advances in cancer research · doi:10.1016/b978-0-12-800092-2.00010-1 · Cited by 140
A Model of Cancer Stem Cells Derived from Mouse Induced Pluripotent Stem Cells
Chen, L., Kasai, T., Li, Y., Sugii, Y., Jin, G., Okada, M., Vaidyanath, A., Mizutani, A., Satoh, A., Kudoh, T., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033544 · Cited by 135
Cioffi, M., Dorado, J., Baeuerle, P. A., & Heeschen, C. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1270 · Cited by 134
Alibolandi, M., Ramezani, M., Sadeghi, F., Abnous, K., & Hadizadeh, F. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.035 · Cited by 133
Wu, J., Zhu, P., Lu, T., Du, Y., Wang, Y., He, L., Ye, B., Liu, B., Yang, L., Wang, J., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.12.015 · Cited by 132
Specific Elimination of CD133+ Tumor Cells with Targeted Oncolytic Measles Virus
Bach, P., Abel, T., Hoffmann, C. M., Gal, Z., Braun, G., Voelker, I., Ball, C. R., Johnston, I., Lauer, U. M., Herold‐Mende, C. C., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2221 · Cited by 130
Localization of the Human β-Catenin Gene (CTNNB1) to 3p21: A Region Implicated in Tumor Development
Kraus, C. S., Liehr, T., Hülsken, J., Behrens, J., Birchmeier, W., Grzeschik, K., & Ballhausen, W. G. (1994) · Genomics · doi:10.1006/geno.1994.1493 · Cited by 130
CD24 regulates sorafenib resistance via activating autophagy in hepatocellular carcinoma
Lü, S., Yao, Y., Xu, G., Chao Hui, Z. H. O. U., Zhang, Y., Sun, J., Jiang, R., Shao, Q., & Chen, Y. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0681-z · Cited by 129
Zhang, J. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1242 · Cited by 124
Markers of pancreatic cancer stem cells and their clinical and therapeutic implications
Gzil, A., Zarębska, I., Bursiewicz, W., Antosik, P., Grzanka, D., & Szylberg, Ł. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-05058-1 · Cited by 124
Zheng, Q., Lin, Z., Xu, J., Lu, Y., Meng, Q., Wang, C., Yang, Y., Xin, X., Li, X., Pu, H., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0305-7 · Cited by 123
Gedaly, R., Galuppo, R., Daily, M. F., Shah, M. B., Maynard, E. C., Chen, C., Zhang, X., Esser, K. A., Cohen, D. A., Evers, B. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099272 · Cited by 121
EpCAM expression in normal, non-pathological tissues
Schmelzer, E. (2007) · Frontiers in bioscience · doi:10.2741/2911 · Cited by 117
Label-retaining liver cancer cells are relatively resistant to sorafenib
Xin, H.-W., Ambe, C. M., Hari, D. M., Wiegand, G. W., Miller, T. C., Chen, J., Anderson, A. J., Ray, S., Mullinax, J. E., Koizumi, T., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-303261 · Cited by 111
Marquardt, J. U., Factor, V. M., & Thorgeirsson, S. S. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.05.003 · Cited by 109
Falciatori, I., Borsellino, G., Haliassos, N., Boitani, C., Corallini, S., Battistini, L., Bernardi, G., Stefanini, M., & Vicini, E. (2003) · The FASEB Journal · doi:10.1096/fj.03-0744fje · Cited by 109
Serova, M., Tijeras‐Raballand, A., Santos, C. D., Albuquerque, M., Paradis, V., Neuzillet, C., Benhadji, K. A., Raymond, É., Faivre, S. J., & Gramont, A. D. E. (2015) · Oncotarget · doi:10.18632/oncotarget.4308 · Cited by 107
Dunsford, H. A., & Sell, S. (1989) · PubMed · Cited by 107
Smoothened as a new therapeutic target for human osteosarcoma
Hirotsu, M., Setoguchi, T., Sasaki, H., Matsunoshita, Y., Gao, H., Nagao, H., Kunigou, O., & Komiya, S. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-5 · Cited by 106
Nio, K., Yamashita, T., Okada, H., Kondo, M., Hayashi, T., Hara, Y., Nomura, Y., Zeng, S. S., Yoshida, M., Hayashi, T., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.06.009 · Cited by 98
Guo, W., Lasky, J. L., & Wu, H. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000203592.04530.06 · Cited by 98
Chen, J., Zheng, D.-X., Yu, X.-J., Sun, H.-W., Xu, Y.-T., Zhang, Y., & Xu, J. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1652540 · Cited by 96
The Expression of CD90/Thy-1 in Hepatocellular Carcinoma: An In Vivo and In Vitro Study
Sukowati, C. H. C., Anfuso, B., Torre, G., Francalanci, P., Crocè, L. S., & Tiribelli, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076830 · Cited by 94
Wang, Z., Tan, J., McConville, C., Kannappan, V., Patricia, T. E., Brown, J. E. P., Ding, J., Armesilla, A. L., Irache, J. M., Mei, Q., et al. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.08.001 · Cited by 94
Self-citationCancer stem cell markers correlate with early recurrence and survival in hepatocellular carcinoma
Guo, Z., Li, L.-Q., Jiang, J.-H., Ou, C., Zeng, L.-X., & Xiang, B.-D. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i8.2098 · Cited by 93
Epigenetic reprogramming modulates malignant properties of human liver cancer
Raggi, C., Factor, V. M., Seo, D., Holczbauer, Á., Gillen, M. C., Marquardt, J. U., Andersen, J. B., Durkin, M. E., & Thorgeirsson, S. S. (2014) · Hepatology · doi:10.1002/hep.27026 · Cited by 92
Zen, Y., Fujii, T., Yoshikawa, S., Takamura, H., Tani, T., Ohta, T., & Nakanuma, Y. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060798 · Cited by 92
The Wnt/β-catenin signaling pathway in liver biology and disease
Behari, J. (2010) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.10.74 · Cited by 91
Kwon, H., Song, K., Han, C. L., Chen, W., Wang, Y., Dash, S., Lim, K., & Wu, T. (2015) · Hepatology · doi:10.1002/hep.28289 · Cited by 88
Wu, C. X., Xu, A., Zhang, C. C., Olson, P., Chen, L., Lee, T. K., Cheung, T. T., Lo, C. M., & Wang, X. Q. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0001 · Cited by 81
Luo, J., Wang, P., Wang, R., Wang, J., Liu, M., Xiong, S., Li, Y., & Cheng, B. (2015) · Oncotarget · doi:10.18632/oncotarget.6672 · Cited by 80
Asai, R., Tsuchiya, H., Amisaki, M., Makimoto, K., Takenaga, A., Sakabe, T., Hoi, S., Koyama, S., & Shiota, G. (2019) · Cancer Medicine · doi:10.1002/cam4.1968 · Cited by 80
CD24-Positive Cells from Normal Adult Mouse Liver Are Hepatocyte Progenitor Cells
Qiu, Q., Hernandez, J. C., Dean, A. M., Rao, P. H., & Darlington, G. J. (2011) · Stem Cells and Development · doi:10.1089/scd.2010.0352 · Cited by 79
Gao, Y., Ruan, B., Liu, W., Wang, J., Yang, X., Zhang, Z., Li, X., Duan, J., Zhang, F., Ding, R., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3488 · Cited by 79
The role of multipotent cancer associated fibroblasts in hepatocarcinogenesis
Sukowati, C. H. C., Anfuso, B., Crocè, L. S., & Tiribelli, C. (2015) · BMC Cancer · doi:10.1186/s12885-015-1196-y · Cited by 79
TGF-β Signaling in Onset and Progression of Hepatocellular Carcinoma
Meindl‐Beinker, N. M., Matsuzaki, K., & Dooley, S. (2012) · Digestive Diseases · doi:10.1159/000341704 · Cited by 79
Muramatsu, S., Tanaka, S., Mogushi, K., Adikrisna, R., Aihara, A., Ban, D., Ochiai, T., Irie, T., Kudo, A., Nakamura, N., et al. (2013) · Hepatology · doi:10.1002/hep.26345 · Cited by 77
Lo, J. H. T., Lau, E. Y.-T., So, F. T. Y., Lu, P., Chan, V. S. F., Cheung, V. C. H., Ching, R. H. H., Cheng, B. Y.-L., Ma, M. K. F., Ng, I. O., et al. (2015) · Liver International · doi:10.1111/liv.12963 · Cited by 77
Kim, J., Lee, H., Park, K.-K., Choi, Y., Nam, J., & Hong, I. (2016) · Oncotarget · doi:10.18632/oncotarget.7954 · Cited by 74
Xia, W. G., Lo, C. M., Poon, R. Y. C., Cheung, T. T., Chan, A. C. Y., Chen, L., Yang, S., Tsao, G. S., & Wang, X. Q. (2017) · Oncotarget · doi:10.18632/oncotarget.16402 · Cited by 73
Galuppo, R., Maynard, E. C., Shah, M. B., Daily, M. F., Chen, C., Spear, B. T., & Gedaly, R. (2014) · PubMed · Cited by 72
Park, N. R., Hoon, J., Jang, J. W., Bae, S. H., Jang, B., Kim, J., Hur, W., Choi, J. Y., & Yoon, S. K. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.06.077 · Cited by 72
Review article: steatosis, the metabolic syndrome and cancer
Bugianesi, E. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02594.x · Cited by 71
Guan, D., Shi, J., Zhang, Y., Zhao, J., Long, L., Chen, T., Zhang, E., Feng, Y., Bao, W., Deng, Y., et al. (2015) · Hepatology · doi:10.1002/hep.28117 · Cited by 67
Hedgehog Signaling and Maintenance of Homeostasis in the Intestinal Epithelium
Büller, N. V. J. A., Rosekrans, S. L., Westerlund, J., & BRINK, G. R. V. D. (2012) · Physiology · doi:10.1152/physiol.00003.2012 · Cited by 66
Hedgehog Signaling Blockade Delays Hepatocarcinogenesis Induced by Hepatitis B Virus X Protein
Arzumanyan, A. L., Sambandam, V., Clayton, M. M., Choi, S. S., Xie, G., Diehl, A. M., Yu, D., & Feitelson, M. A. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2329 · Cited by 66
Thy-1 Is a Component Common to Multiple Populations of Synaptic Vesicles
Jeng, C., McCarroll, S. A., Martin, T. F. J., Floor, E., Adams, J., Krantz, D. E., Butz, S., Edwards, R. H., & Schweitzer, E. S. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.3.685 · Cited by 64
Wang, C., Wang, M.-D., Cheng, P., Huang, H., Dong, W., Zhang, W., Li, P., Lin, C., Pan, Z., Wu, M., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2016.493 · Cited by 64
The CD24 surface antigen in neural development and disease
Gilliam, D. T., Menon, V., Bretz, N. P., & Pruszak, J. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.12.011 · Cited by 62
Human Liver-Derived Stem Cells
Strain, A. J., Crosby, H. A., Nijjar, S. S., Kelly, D. A., & Hübscher, S. G. (2003) · Seminars in Liver Disease · doi:10.1055/s-2004-815563 · Cited by 61
Early molecular and genetic determinants of primary liver malignancy
Feitelson, M. A., Pan, J., & Lian, Z. (2004) · Surgical Clinics of North America · doi:10.1016/s0039-6109(03)00226-3 · Cited by 58
Mimeault, M., Johansson, S. L., Hénichart, J., Depreux, P., & Batra, S. K. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1013 · Cited by 58
CD133+ cancer stem cells promoted by VEGF accelerate the recurrence of hepatocellular carcinoma
Liu, K., Hao, M., Ouyang, Y., Zheng, J., & Chen, D. (2017) · Scientific Reports · doi:10.1038/srep41499 · Cited by 57
Chen, Y., Lin, P., Ming, Y., Huang, W.-C., Chen, R., Chen, P., & Chu, P. (2017) · BMC Cancer · doi:10.1186/s12885-017-3460-9 · Cited by 54
Zhang, Q., Lu, C., Fang, T., Wang, Y., Hu, W., Qiao, J., Liu, B., Liu, J., Chen, N., Li, M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.2898 · Cited by 52
EpCAM-Targeted Therapy for Human Hepatocellular Carcinoma
Ogawa, K., Tanaka, S., Matsumura, S., Murakata, A., Ban, D., Ochiai, T., Irie, T., Kudo, A., Nakamura, N., Tanabe, M., et al. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3430-7 · Cited by 52
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases
Kumar, R., Juillerat‐Jeanneret, L., & Golshayan, D. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01516 · Cited by 50
Statistical Mechanics Model for the Dynamics of Collective Epigenetic Histone Modification
Zhang, H., Tian, X., Mukhopadhyay, A., Kim, K. S., & Xing, J. (2014) · Physical Review Letters · doi:10.1103/physrevlett.112.068101 · Cited by 49
Stem Cell Markers Predict the Response to Sorafenib in Patients with Hepatocellular Carcinoma
Kim, B. H., Park, J., Kim, J. S., Lee, S.-K., & Hong, E. K. (2019) · Gut and Liver · doi:10.5009/gnl18345 · Cited by 49
Sun, L., Zhang, L., Chen, J., Li, C., Sun, H., Wang, J., & Xiao, H. P. (2019) · Cancer Research and Treatment · doi:10.4143/crt.2019.444 · Cited by 46
Liu, Y., Yang, Q., Bai, Z.-H., et al. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.104 · Cited by 45
Self-citationHighly tumorigenic hepatocellular carcinoma cell line with cancer stem cell-like properties
Lacoste, B., Raymond, V., Cassim, S., Lapierre, P., & Bilodeau, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171215 · Cited by 45
Aquaporin 3 maintains the stemness of CD133+ hepatocellular carcinoma cells by activating STAT3
Wang, Y., Wu, G., Fu, X., Xu, S., Wang, T., Zhang, Q., & Yang, Y. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1712-0 · Cited by 42
Liu, H., Zhang, W., Jia, Y., Yu, Q., Grau, G. E., Peng, L., Ran, Y., Yang, Z., Deng, H., & Lou, J. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.340 · Cited by 41
Evidence of CD90+CXCR4+ cells as circulating tumor stem cells in hepatocellular carcinoma
Zhu, L., Zhang, W., Wang, J., & Liu, R. (2015) · Tumor Biology · doi:10.1007/s13277-015-3196-6 · Cited by 40
Doxorubicin and 5-fluorouracil resistant hepatic cancer cells demonstrate stem-like properties
Vu, N. B., Nguyen, T. T., Tran, L. C.-D., Do, C. D., Bắc, N. H., Phan, N. K., & Pham, P. V. (2012) · Cytotechnology · doi:10.1007/s10616-012-9511-9 · Cited by 39
Chun, H. W., & Hong, R. (2016) · Oncology Letters · doi:10.3892/ol.2016.4884 · Cited by 37
Ying, Y., Liu, Q., Li, Z., Zhang, R., Jia, C., Yang, Z., Zhao, H., Ya, S., Mao, R., Ailijiang, T., et al. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy010 · Cited by 36
Targeting Epigenetic Readers in Cancer
Rosner, M., & Hengstschläger, M. (2012) · New England Journal of Medicine · doi:10.1056/nejmc1211175 · Cited by 34
Turcios, L. M., Vilchez, V., Acosta, L. F., Pratheeshkumar, P., Butterfield, D. A., Mitov, M. I., Martí, F., & Gedaly, R. (2017) · Digestive and Liver Disease · doi:10.1016/j.dld.2017.01.146 · Cited by 34
Tsuchiya, A., Kamimura, H., Takamura, M., Yamagiwa, S., Matsuda, Y., Sato, Y., Nomoto, M., Ichida, T., & Aoyagi, Y. (2009) · Hepatology Research · doi:10.1111/j.1872-034x.2009.00559.x · Cited by 33
Zhang, M., Zhang, W., Wu, Z., Liu, S., Sun, L., Zhong, Y., Zhang, X., Kong, X., Qian, P., Zhang, H., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6572 · Cited by 33
Barboni, E., Gormley, A. M., Rivero, F. B. P., et al. (1991) · PubMed · Cited by 31
Ubenimex suppresses Pim-3 kinase expression by targeting CD13 to reverse MDR in HCC cells
Guo, Q., Sui, Z., Xu, W., Quan, X., Sun, J., Xiao, L., Ji, H., & Jing, F. (2017) · Oncotarget · doi:10.18632/oncotarget.20194 · Cited by 29
Deregulation of Frizzled Receptors in Hepatocellular Carcinoma
Chan, K. K., & Lo, R. C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010313 · Cited by 29
Zhao, R., ZHOU, J., Chen, K., Gong, J., LIU, J., HE, J. Y., GUAN, P., LI, B., & QIN, Y. (2015) · Neoplasma · doi:10.4149/neo_2016_036 · Cited by 22
Ko, C., Li, C., Wu, M., & Chu, P. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6794 · Cited by 21
Liu, Y., Lu, L.-F., Li, C., Sun, N., Guo, J.-Y., Huang, Y., Yeh, C., & Chao, C. C. ‐. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0463 · Cited by 21
Self-citationNi, C., Yang, Q., Zhang, J., Liu, Y., Xu, J., Hu, H., Wu, Q., Wu, Q., Wang, Y., & Zhang, J. (2016) · Oncotarget · doi:10.18632/oncotarget.12822 · Cited by 20
Self-citationTherapeutic targeting of the thrombospondin-1 receptor CD47 to treat liver cancer
Roberts, D. D., Kaur, S., & Soto‐Pantoja, D. R. (2015) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-015-0283-9 · Cited by 16
Distribution of cancer stem cells in two human brain gliomas
Peng, L., Fu, J., Wang, W., Hofman, F. H., Chen, T., & Chen, L. (2018) · Oncology Letters · doi:10.3892/ol.2018.9824 · Cited by 16
Circulating cancer stem cells: a novel prognostic predictor of hepatocellular carcinoma.
Chiba, T., Kanai, F., Iwama, A., & Yokosuka, O. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2304-3881.2012.09.02 · Cited by 12
MicroRNA-449a maintains self-renewal in liver cancer stem-like cells by targeting Tcf3
Zhang, Q., Yang, Z., Shan, J., Liu, L., Liu, C., Shen, J., Chen, X., Xu, Y., Chen, J., Ma, Q., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22705 · Cited by 11
FH535 suppresses the proliferation and motility of hepatocellular carcinoma cells
Tomizawa, M., Shinozaki, F., Motoyoshi, Y., Sugiyama, T., Yamamoto, S., & Ishige, N. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3220 · Cited by 9
(1999) · doi:10.1002/(sici)1521-1878(199912)22:1<1021::aid-bies6>3.0.co;2-p
Cited by
IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma
Xu, J., Lin, H., Wu, G., Zhu, M., & Li, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.760971 · Cited by 228
Gajos-Michniewicz, A., & Czyz, M. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2023.02.050 · Cited by 89
Roles of microRNAs in Gastrointestinal Cancer Stem Cell Resistance and Therapeutic Development
Hwang, G.-R., Yuen, J. G., & Ju, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041624 · Cited by 15
Metadata
- Authors
- Liu, Y.-C., Yeh, C.-T., & Lin, K.-H.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2020-05-26
- Volume
- 9
- Issue
- 6
- Pages
- 1331
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W3029777522
- Cited by
- 253
- References
- 186
- FWCI
- 11.23
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.